Chondrogenix Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Grant
- (Cancelled)
- Financing Rounds
-
3
Chondrogenix General Information
Description
Provider of regenerative therapy designed focused on cartilage regeneration. The company's technology converts multiple starting cell types to functional chondrocytes capable of spontaneously forming cartilage, providing the healthcare professionals with a safe, efficient and scalable source of therapeutic cells for the treatment of osteoarthritis.
Contact Information
Website
www.chondrogenix.comCorporate Office
- 25 Cambridge Science Park
- Milton Road
- Cambridge CB4 0FW
- England, United Kingdom
Corporate Office
- 25 Cambridge Science Park
- Milton Road
- Cambridge CB4 0FW
- England, United Kingdom
Chondrogenix Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Chondrogenix Signals
Chondrogenix Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Chondrogenix FAQs
-
When was Chondrogenix founded?
Chondrogenix was founded in 2017.
-
Where is Chondrogenix headquartered?
Chondrogenix is headquartered in Cambridge, United Kingdom.
-
What is the size of Chondrogenix?
Chondrogenix has 2 total employees.
-
What industry is Chondrogenix in?
Chondrogenix’s primary industry is Biotechnology.
-
Is Chondrogenix a private or public company?
Chondrogenix is a Private company.
-
What is Chondrogenix’s current revenue?
The current revenue for Chondrogenix is .
-
Who are Chondrogenix’s investors?
SBRI Healthcare and University of Bristol have invested in Chondrogenix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process